Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Dutch Asymptomatic Mitral Regurgitation Trial (Dutch AMR)

This study has been terminated.
(low inclusion rate)
Sponsor:
Collaborators:
Leiden University Medical Center
The Interuniversity Cardiology Institute of the Netherlands
WCN, Dutch Network for Cardiovascular Research
Information provided by (Responsible Party):
S.A.J. Chamuleau, UMC Utrecht
ClinicalTrials.gov Identifier:
NCT01708265
First received: October 11, 2012
Last updated: November 22, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: February 2021
  Estimated Primary Completion Date: February 2021 (Final data collection date for primary outcome measure)